Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Instead of discussing problems, or even finding solutions, those who led the G6 are [now] showering U.S. President Donald Trump with compliments and presenting him with gifts.